PIK3CA Oncogenic Mutations in Breast and Colon Cancers: Development of Targeted Anticancer Drugs and Diagnostics

Project title:  PIK3CA Oncogenic Mutations in Breast and Colon Cancers: Development of Targeted Anticancer Drugs and Diagnostics
Coordinator: Dr. Argiris Efstratiadis; BRF Academy of Athens
Funding:  OPERATIONAL PROGRAMMES 'COMPETITIVENESS & ENTREPRENEURSHIP' National Strategic Reference Framework NSRF 2007-1013 National Action: 'COOPERATION', Sub-action II: 'Large Scale Cooperative Projects
Total Budget: 2.453.625 €

Tags: drug discovery


Contact us

Address:20, Delfon Street
151 25 Marousi,
Athens-Greece
Phone:+30-210-6622386
Fax:+30-210-6622332
Email:This email address is being protected from spambots. You need JavaScript enabled to view it.